Bevacizumab and Radiation Therapy for Sarcomas

Clinical trial NCT00356031 · COMPLETED

Trial details

NCT number: NCT00356031
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Soft Tissue Sarcoma Fibrous Histiocytoma Liposarcoma Leiomyosarcoma Fibrosarcoma Synovial Sarcoma

Start date: 2006-07-01
Primary completion: 2010-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.